- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 279.85M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $3.67M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $3.67M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $214.93K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $166.41K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $7.51M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $5.36M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $30.82M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $29.31M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $844.78K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $997.12K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $28.03M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $27.75M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 237.87M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $358.44K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $1.54M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.48M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $433.06K |
| Net Income | Q1 2025 · Mar 31, 2024 | $52.92K |
| Operating Income | Q1 2025 · Mar 31, 2024 | $129.6K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $870.91K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $5.02M |
| Revenue | Q1 2025 · Mar 31, 2024 | $5.89M |